Phosphatidylserine (PS)
Phospholipid concentrated in brain cell membranes, essential for cell signalling, apoptosis regulation, and neurotransmitter release. Biphasic plasma kinetics with rapid cellular uptake. Supplementation increases phosphatidylserine content in cell membranes. Modern supplements use soy or sunflower-derived PS.
Projected serum levels — 100 mg, once daily
Maintenance schedule: 100 mg once daily (oral).
Modeled steady state after ~1 days: peak ≈ 1.8 mg, trough ≈ 0.002 mg body load. Population-based estimate over 15 days for a 100 mg dose at a 70 kg reference body mass — the interactive app scales curves to your doses, timing, and body mass.
Key facts
- Category
- Nootropic
- Route modeled
- Oral
- Model confidence
- inferred
- Half-life
- 14 min
- Common dose
- 100 mg
- Suggested maximum
- 300 mg/day
- Reference dose range
- 50–300 mg (single dose)
- Suggested cadence
- once daily
Research behind this entry
-
Effect of phosphatidylserine on cognitive function in the elderly: a systematic review and meta-analysis
Systematic review and meta-analysis of 5 RCTs (783 participants) and 4 pre-post studies (178 participants) concluded that phosphatidylserine has a positive effect on memory in older adults with cognitive decline.
-
Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints
Double-blind RCT in 78 elderly subjects (50-69 years) showed 100-300 mg/day soy-derived PS for 6 months significantly improved memory scores in the subgroup with lowest baseline performance.
-
Effects of phosphatidylserine on exercising humans
Review of exercise studies demonstrated 300-800 mg/day phosphatidylserine blunts cortisol response to exercise stress and may improve exercise capacity and recovery.
-
Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints.
This citation reports a human primary study involving Phosphatidylserine (PS). It does not by itself establish a qualified dose, safety profile, efficacy claim, or pharmacokinetic route for this record.
4 published studies referenced in the app, each with a plain-language summary.